探地雷达拮抗剂;GPR Antagonists;;InformationJMS-17-2 JMS-17-2 is a potent and selective small-molecule antagonist of CX3C chemokine receptor 1 (CX3CR1/GPR13) with IC50 of 0.32 nM. JMS-17-2 is used in the research of metastatic disease in breast cancer patients.TargetsGPR13 (Cell-free assay) 0.32 nM